Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medlive Technology CoHKSE:02192 +0.32%90 FCF Margin % is 20.06% as of Dec. 2025, which is 0% below its 10-year median of 20.08. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Medlive Technology Co ranks better than 91.75% on this metric.
The historical rank and industry rank for Medlive Technology Co's FCF Margin % or its related term are showing as below:
HKSE:02192'
s FCF Margin % Range Over the Past 10 Years
Min: 14.93 Med: 20.08 Max: 51.71
Current: 18.96
During the past 8 years, the highest FCF Margin % of Medlive Technology Co was 51.71%. The lowest was 14.93%. And the median was 20.08%.
HKSE:02192's FCF Margin % is ranked better than 91.75% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.12
vs HKSE:02192: 18.96
Medlive Technology Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medlive Technology Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02192 vs VEEV, BTSG, HQY: FCF Margin % Comparison
For the Health Information Services subindustry, Medlive Technology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) has a FCF Margin % of 20.06% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medlive Technology Co and its competitors. This is near median its historical median of 20.08. Over the past decade, Medlive Technology Co's FCF Margin % has ranged from 14.93 to 51.71. According to the industry distribution chart, Medlive Technology Co ranks #55 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is Medlive Technology Co's FCF Margin % too high?
Medlive Technology Co's current FCF Margin % of 20.06% is near median its 10-year median of 20.08. Over the past 10 years, this metric has ranged from a low of 14.93 to a high of 51.71. The Healthcare Providers & Services industry median FCF Margin % is 3.12. Medlive Technology Co's value of 20.06% is 542.9% above this industry median. Based on the distribution chart, Medlive Technology Co ranks #55 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #55 out of 667 companies for FCF Margin %. This places Medlive Technology Co in the top 8% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.12. Medlive Technology Co's value of 20.06% is 542.9% above this benchmark. Historically, Medlive Technology Co's own FCF Margin % has ranged from 14.93 to 51.71 over the past decade. While the company's 10-year median is 20.08 vs. the industry median of 3.12, Medlive Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.12, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current FCF Margin % of 20.06% is 542.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medlive Technology Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current FCF Margin % is 20.06%, which is near median its own 10-year median of 20.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.83 — trading 47.7% below its estimated fair value. The current FCF Margin % is 20.06%, which is near median its 10-year median of 20.08 and 542.9% above the Healthcare Providers & Services industry median of 3.12. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current FCF Margin % is 20.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?
Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued.
The current stock price of HK$7.83 is trading 47.7% below its estimated GF Value™ of HK$14.95.
GuruFocus considers Medlive Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02192:
FCF Margin %: 20.06% (near median its 10-year median of 20.08)
GF Value™: HK$14.95 vs. price of HK$7.83 (47.7% below fair value)
Industry Position: 542.9% above the Healthcare Providers & Services median (#55 of 667)
No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score
Get the complete analysis for HKSE:02192
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02192 has been successfully added to your 
